PUBLISHER: The Business Research Company | PRODUCT CODE: 1825810
PUBLISHER: The Business Research Company | PRODUCT CODE: 1825810
Metagenomic sequencing is a technique used to analyze the genetic material from an entire community of microorganisms in a specific environment without culturing individual species. This method involves extracting DNA directly from environmental samples, such as soil, water, or the human gut, and then sequencing it using high-throughput sequencing technologies.
The main products and services in the metagenomic sequencing market include reagents and consumables, instruments, sequencing services, and analysis and data interpretation solutions. Reagents and consumables encompass the chemical substances, kits, and disposable items used in laboratory experiments and procedures. The various technologies include 16S rRNA sequencing, shotgun metagenomic sequencing, whole-genome sequencing and de novo assembly, and metatranscriptomics. These technologies are used in various applications such as clinical diagnostics, environmental remediation, gut microbe characterization, drug discovery, biofuel production, agriculture, and other fields.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The metagenomic sequencing market research report is one of a series of new reports from The Business Research Company that provides metagenomic sequencing market statistics, including metagenomic sequencing industry global market size, regional shares, competitors with a metagenomic sequencing market share, detailed metagenomic sequencing market segments, market trends, and opportunities, and any further data you may need to thrive in the metagenomic sequencing industry. This metagenomic sequencing research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The metagenomic sequencing market size has grown rapidly in recent years. It will grow from $2.13 billion in 2024 to $2.5 billion in 2025 at a compound annual growth rate (CAGR) of 17.2%. The growth in the historic period can be attributed to increasing involvement of the government, the growing number of metagenome sequencing research projects, growing application of metagenomics in genomics and diagnostics research, the availability of research funding, the development of NGS data analysis tools.
The metagenomic sequencing market size is expected to see rapid growth in the next few years. It will grow to $4.54 billion in 2029 at a compound annual growth rate (CAGR) of 16.1%. The growth in the forecast period can be attributed to decreasing computational costs, growing focus on discovering novel biomolecules of interest, increasing adoption of high-throughput sequencing technologies, demand for personalized medicine and disease diagnosis, surge in prevalence of infectious diseases. Major trends in the forecast period include innovative technologies, metagenomics utilizes advanced genomic technologies, augmented R&D funding, advancements in sequencing technology, NGS data analysis using big data.
The forecast of 16.1% growth over the next five years reflects a modest reduction of 0.7% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. infectious disease surveillance by inflating prices of nanopore sequencing devices and microbiome analysis kits imported from the UK and China, resulting in delayed pathogen identification and higher public health laboratory costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The growing prevalence of infectious diseases is expected to drive the expansion of the metagenomic sequencing market. Infectious diseases are caused by harmful microorganisms, such as bacteria, viruses, parasites, or fungi, that can spread from one person to another, either directly or indirectly. Conditions that compromise the immune system, such as HIV/AIDS, cancer treatments, and autoimmune disorders, can increase susceptibility to infectious diseases. Metagenomic sequencing offers an effective and flexible method for studying infectious diseases, providing valuable insights into pathogen diversity, transmission patterns, antimicrobial resistance, and outbreak monitoring. For example, in January 2023, the Government of Canada reported that 135 rabies samples were submitted in October 2022, and 159 samples were submitted in November 2022. Additionally, the Centers for Disease Control and Prevention (CDC) reported a 5.9% increase in tuberculosis (TB) cases in the U.S. from 7,874 in 2021 to 8,331 in 2022. Consequently, the rise in infectious disease prevalence is driving growth in the metagenomic sequencing market.
Key players in the metagenomic sequencing market are concentrating on enhancing sequencing services to improve accuracy, throughput, and cost-effectiveness. Sequencing services involve advanced genomic technologies enabling the sequencing of longer DNA fragments, providing a more detailed view of genetic structures compared to traditional short-read methods. For instance, Clinical Microbiomics A/S introduced advanced long-read sequencing services in April 2024, including 16S, ITS, 18S rRNA, custom gene sequencing, and comprehensive genomics and metagenomics. These services offer unparalleled resolution and quality in microbial analysis, facilitating detailed insights into microbial communities and the creation of high-quality metagenome-assembled genomes.
In January 2022, Illumina Inc. acquired IDbyDNA to bolster its infectious disease diagnostics and microbial genomics capabilities. This acquisition integrates IDbyDNA's expertise in metagenomic sequencing and bioinformatics with Illumina's portfolio of sequencing technologies and analytical solutions, enhancing their position in pathogen surveillance and infectious illness testing.
Major companies operating in the metagenomic sequencing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Merck Co. & KGaA, Eurofins Scientific SE, PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Beijing Genomics Institute Group, Azenta Inc., Promega Corporation, Novogene Co. Ltd., Oxford Nanopore Technologies plc, Zymo Research Corporation, Metagenomi Inc., Psamogen Inc., IntegraGen SA, Karius Inc., DNAStar Inc., Macrogen Inc., Takara Bio Inc., Arc Bio LLC, Microsynth AG, Computomics GmbH, COSMOSID Inc., Phase Genomics Inc., Era7 Bioinformatics GmbH
North America was the largest region in the metagenomic sequencing market in 2024. Asia-Pacific is expected to be the fastest growing region in the market. The regions covered in the metagenomic sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the metagenomic sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The metagenomic sequencing market includes revenues earned by entities by providing services such as sample preparation, sequencing, metagenomic profiling, and data analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The metagenomic sequencing market also includes sales of sequencing platforms, bioinformatics software, DNA extraction kits, and sequencing reagents. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Metagenomic Sequencing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on metagenomic sequencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for metagenomic sequencing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The metagenomic sequencing market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.